相关阅读

Array ( [0] => Array ( [relateid] => 812695 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/812695.html [wapUrl] => https://m.jnnc.com/p/812695.html [published_timestamp] => 1607905168 [published] => 1607905168 [pv] => 152 [virtual_pv] => 0 [all_pv] => 152 [title] => 巴林批准中国国药集团新冠疫苗注册上市 [has_thumb] => 0 [thumb] => ) [1] => Array ( [relateid] => 812774 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/812774.html [wapUrl] => https://m.jnnc.com/p/812774.html [published_timestamp] => 1607928509 [published] => 1607928509 [pv] => 171 [virtual_pv] => 0 [all_pv] => 171 [title] => 巴林批准中国国药集团新冠疫苗注册上市 [has_thumb] => 0 [thumb] => ) [2] => Array ( [relateid] => 814212 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/814212.html [wapUrl] => https://m.jnnc.com/p/814212.html [published_timestamp] => 1609310702 [published] => 1609310702 [pv] => 272 [virtual_pv] => 0 [all_pv] => 272 [title] => 国药集团中国生物北京公司新冠病毒灭活疫苗Ⅲ期临床试验期中分析数据发布 [has_thumb] => 0 [thumb] => ) [3] => Array ( [relateid] => 801001 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/801001.html [wapUrl] => https://m.jnnc.com/p/801001.html [published_timestamp] => 1592439832 [published] => 1592439832 [pv] => 366 [virtual_pv] => 0 [all_pv] => 366 [title] => 国药新冠病毒灭活疫苗受试者全部产生抗体 [has_thumb] => 0 [thumb] => ) [4] => Array ( [relateid] => 814357 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/814357.html [wapUrl] => https://m.jnnc.com/p/814357.html [published_timestamp] => 1609402336 [published] => 1609402336 [pv] => 328 [virtual_pv] => 0 [all_pv] => 328 [title] => 官方：中国新冠疫苗的生产能力能够满足国内大规模接种需求 [has_thumb] => 0 [thumb] => ) )
• 巴林批准中国国药集团新冠疫苗注册上市
• 巴林批准中国国药集团新冠疫苗注册上市
• 国药集团中国生物北京公司新冠病毒灭活疫苗Ⅲ期临床试验期中分析数据发布
• 国药新冠病毒灭活疫苗受试者全部产生抗体
• 官方：中国新冠疫苗的生产能力能够满足国内大规模接种需求